CTTI would like to welcome newest member Dana-Farber Cancer Institute. As a leading organization in cancer treatment and research, it represents one of many key stakeholders that CTTI engages to collaboratively improve the quality and efficiency of the clinical trials enterprise. Michele Russell-Einhorn, Senior Director of the Office for Human Research Studies, will represent the organization on our Steering Committee, and we look forward to her contribution.